Clinical trial
Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy
NCT04125771 is registered in ClinicalTrials.gov with Aljazeera Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy
- Lead sponsor
- Aljazeera Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 16, 2020
- Completion date
- October 1, 2020
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.